Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

South Africa aims to more than double daily COVID-19 vaccinations over next month

Fri, 25th Jun 2021 11:10

JOHANNESBURG, June 25 (Reuters) - South Africa aims to more
than double the rate of daily COVID-19 vaccinations over the
next month to more than 200,000 as more Pfizer and
Johnson & Johnson shots arrive, health officials said on
Friday.

The country's vaccination campaign has started slowly, set
back by the revelation that AstraZeneca's vaccine is
much less effective against the dominant local coronavirus
variant.

The government found it difficult to secure supplies from
other manufacturers given huge global demand.

So far, only 2.5 million vaccinations have been administered
using either the one-shot J&J vaccine or the two-shot Pfizer
alternative, out of a population of 60 million people, health
ministry data show.

"Now we are able to do, and we have done, just over 100,000
a day for the last two days. Our target for next week is to get
up to 150,000 a day, and by mid-July 200,000 a day with a target
by the end of July of being able to have enough resources in the
field to do 250,000 vaccinations a day," Nicholas Crisp, a
senior official involved in the vaccine rollout, told a news
conference.

"The president has asked us to chase a target of 300,000 a
day, and I think all of us in the vaccination response programme
are going to work hard to try and get to that point," he added.

Acting health minister Mmamoloko Kubayi-Ngubane said Pfizer
had delivered nearly 4.5 million vaccine doses in the second
quarter and had committed to provide just over 15.5 million
doses in the third quarter, including nearly 2.1 million doses
in July.

In total South Africa has secured 30 million Pfizer shots
and 31 million from J&J.

J&J has delivered 500,000 shots for a research study
targeting healthcare workers, 300,000 last week and 1.2 million
on Thursday, Kubayi-Ngubane said. A further 500,000 J&J doses
are expected soon, but the timing is not yet confirmed.

"With this flow of vaccines, we will be able to press ahead
with the vaccination of frontline workers sector by sector," she
said. So far South Africa has started immunising health workers,
those aged over 60 years and education sector employees.

From July 15, the over-50s will start getting the vaccine,
the acting minister said.
(Reporting by Alexander Winning, editing by Louise Heavens)

More News
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.